St. Louis University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, St. Louis University sits in the top decile of US sponsors by registered trial count (#228 of 15,742 sponsors by registered trial count).

107 total trials 12 currently recruiting 63 completed top decile by trial count

St. Louis University: 107 sponsored US clinical trials, 12 recruiting.

St. Louis University sponsors 107 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 63 completed. 12 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use, with 3 trials.

Top-decile sponsor footprint

St. Louis University ranks in the top decile of sponsors by registered trial count (#228 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 14/100

63 of 90 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (70.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

107 total, page 1 of 3

RECRUITING NA

Reduction of Bacterial Seeding in Total Shoulder Arthroplasty

NCT07406893

RECRUITING Phase 4

Efficacy of Methylprednisolone for Pain Control After ACL Repair

NCT07158476

RECRUITING NA

Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance

NCT07024940

RECRUITING NA

Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease

NCT06859528

RECRUITING NA

Preconception Intervention for Incarcerated Women With Substance Use

NCT05854836

RECRUITING NA

MAP for Coaches: Translating Sports Injury Prevention Knowledge to Youth Sport Coaches

NCT05718063

RECRUITING Phase 2

Testosterone Treatment in Men with Chronic Kidney Disease

NCT05249634

RECRUITING NA

Mindfulness in Endometrial and Cervical Cancer

NCT04512144

RECRUITING

Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)

NCT03999983

RECRUITING Phase 3

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

NCT03823534

RECRUITING

APOL1 Genetic Testing in African Americans

NCT05656261

RECRUITING Phase 3

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

NCT03295981

ACTIVE NOT RECRUITING

Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney Transplantation

NCT04414111

ACTIVE NOT RECRUITING

Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients

NCT06153641

ACTIVE NOT RECRUITING NA

Texting for Diabetes

NCT03025984

ACTIVE NOT RECRUITING

Alpha-1 Antitrypsin Deficiency Adult Liver Study

NCT02014415

NOT YET RECRUITING NA

Effects of Caffeine on Chess Performance and Cognitive Function in Professional Chess Players

NCT07641335

COMPLETED Phase 4

SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty

NCT05919888

TERMINATED NA

Neuromodulation for Children With Cystic Fibrosis Experiencing Chronic Abdominal Pain

NCT05515250

COMPLETED Phase 4

Ketorolac on Postoperative Pain Reduction in Pediatric Patients with Adenotonsillectomy

NCT05074056

COMPLETED NA

Effect of Exercise on Biomarkers in SCT

NCT04273022

COMPLETED

Family Relationships and Nutrition in TGGD Youth and Young Adults

NCT05163860

TERMINATED

Comparison of Chitodex Gel Vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis

NCT05083741

TERMINATED Phase 2

Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen

NCT04534881

TERMINATED

Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

NCT04551144

COMPLETED NA

Postoperative Pain and Healing in Teeth Treated With GentleWave or EndoActivator

NCT04552132

COMPLETED NA

Gyn Onc Prehab Study

NCT04298827

TERMINATED NA

Effect of Bracing Versus No Bracing in Stable Thoracolumbar Compression and Burst Fractures

NCT03952182

COMPLETED Phase 4

Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

NCT04210427

COMPLETED NA

Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies

NCT03837522

COMPLETED NA

Nasal Bridles and Repeat Endoscopic Procedures for Endoscopic Nasoenteric Tubes

NCT03966157

TERMINATED Phase 4

Postoperative Pain Control & Relief in Neonates

NCT03677830

COMPLETED

When do School-aged Patients Return to School After ACL Surgery?

NCT03929237

COMPLETED

Vulvodynia: Identification of Potential Relevant Biomarkers

NCT02981433

COMPLETED

S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain

NCT03003845

TERMINATED NA

A Prospective Study Comparing Suture Anchor and Soft Tissue Pectoralis Major Tendon Techniques for Biceps Tenodesis

NCT03529162

COMPLETED NA

Meditation for NICU Moms

NCT03574766

COMPLETED Early Phase 1

Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I

NCT03445702

COMPLETED NA

Training Intrinsic Foot Muscles

NCT03670563

COMPLETED NA

Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing

NCT03644849

COMPLETED

Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis

NCT03694093

COMPLETED Early Phase 1

Antibiotics Prior to Mini-screw Implant Insertion

NCT03582605

TERMINATED NA

Propel Stent vs Kenalog-soaked Nasopore After Frontal Drill-out

NCT03534362

COMPLETED NA

Compliance Feasibility Study for Remote Phase 2 Cardiac Rehabilitation

NCT03491982

TERMINATED NA

The Effect of a 30-day Automated Text Messaging Intervention on Hospital Based Acute Care Encounters Following Ileostomy

NCT03424954

TERMINATED NA

Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome

NCT03419156

COMPLETED Early Phase 1

Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise

NCT03445104

COMPLETED

A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries

NCT03422211

TERMINATED NA

Three Month Automated Messaging Intervention

NCT03013192

COMPLETED NA

Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease

NCT03161327

Page 1 of 3 Next →

What is open in the St. Louis University pipeline

12 recruiting of 107 indexed (11% open); 63 completed (59%).

Phase mix: 12 late (III/IV) vs 12 early (I/II) (balanced across stages).

Top condition: Opioid Use (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

St. Louis University: open-pipeline peers nationwide

Peers matched on 107 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

St. Louis University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200 5%10%15%20% Total trials Recruiting share St. Louis UniversityGeisinger ClinicUniversity of ConnecticutNemours Children's ClinicAugusta UniversityAstellas Pharma Global DevelopmentADC Therapeutics S.A.Adrian VellaAIDS Malignancy Consortium
St. Louis University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

St. Louis University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 107 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this St. Louis University page

107 registered trials is a research-attention snapshot, not an endorsement of St. Louis University or any single study.

  • 12 of St. Louis University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Opioid Use is the condition St. Louis University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

St. Louis University pipeline card: 107 registered trials from official public datasets.Report a data error.